Latest / Research To Practice | Oncology Videos
Non-Hodgkin Lymphoma | Oncology Today with Dr Neil Love: Bispecific Antibodies in the Management of Non-Hodgkin Lymphoma with Dr Matthew Matasar
Featuring an interview with Dr Matthew Matasar, including the following topics:
Rationale for the evaluation of anti-CD20 x CD3 bispecific antibodies in the treatment of non-Hodgkin lymphoma (NHL) (0:00)
Incidence, severity and time course of cytokine release syndrome, neurotoxicity/ICANS and other adverse events associated with bispecific antibodies; recommended mitigation and management protocols (4:39)
Activity of and similarities and differences among the various bispecific antibodies for NHL (12:20)
Eligibility, efficacy and durability of response with mosunetuzumab, glofitamab…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.